---
title: "MTTP"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene MTTP"
tags: ['MTTP', 'LipoproteinTransport', 'Hypobetalipoproteinemia', 'Abetalipoproteinemia', 'Steatosis', 'LipidMetabolism', 'DrugResponse', 'GeneticMutation']
---

# Information about Gene MTTP

## Genetic Position, Pathology, and Function
The MTTP gene is located on chromosome 4q24 and encodes for a microsomal triglyceride transfer protein. This protein is involved in the transfer of lipids during the assembly and secretion of apolipoprotein B-containing lipoproteins, which play a role in the transport of lipids from the liver and intestine to peripheral tissues. Mutations in MTTP have been associated with forms of hypocholesterolemia and steatosis.

## Function for Gene
The MTTP gene encodes for the microsomal triglyceride transfer protein, which plays a key role in the assembly and secretion of apolipoprotein B-containing lipoproteins. These lipoproteins are responsible for transporting lipids from the liver and intestine to the peripheral tissues.

## External IDs and Genomic Location
- HGNC: 7456
- NCBI Entrez: 4547
- Ensembl: ENSG00000138668
- OMIM: 157147
- UniProtKB/Swiss-Prot: P55157
- Genomic Location: Chromosome 4q24

## AA Mutation List and Mutation Type with dbSNP ID
- c.1018A>G (p.Asn340Ser) - rs2069952
- c.744+24C>T - rs1800803
- c.1387A>G (p.Asn463Ser) - rs137854831
- c.2545A>G (p.His849Arg) - rs2285803

## Somatic SNVs/InDels with dbSNP ID
- c.2936C>T (p.Ala979Val) - rs142286820

## Related Disease
Mutations in MTTP have been associated with hypobetalipoproteinemia, abetalipoproteinemia, and steatosis.

## Treatment and Prognosis
Treatment options for individuals with MTTP mutations depend on the specific type of mutation and associated symptoms. In general, treatment may involve dietary modifications and lipid-lowering medications. Prognosis also varies depending on the severity of symptoms and success of treatment.

## Drug Response
Individuals with MTTP mutations may respond differently to different lipid-lowering medications, and drug response should be monitored closely.

## Related Papers
- Kane JP, Havel RJ (Nov 1996). "Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins". In Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic and Molecular Bases of Inherited Disease (7th ed.). New York: McGraw-Hill. pp. 1853–72. PMID 2141329.
- Hussain MM, Siddiqi SA, Mahley RW, Hobbs HH (2016). "Microsomal triglyceride transfer protein". Physiology. 31 (4): 362–79. doi:10.1152/physiol.00032.2015. PMID 27390251.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**